Trial Profile
THRIVE registry of patients with urea cycle disorders, including real-world experience with ammonia-scavenging agents (sodium phenylbutyrate, glycerol phenylbutyrate and sodium benzoate)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2013
Price :
$35
*
At a glance
- Drugs Glycerol phenylbutyrate (Primary) ; Sodium phenylbutyrate (Primary) ; Sodium benzoate
- Indications Hyperammonaemia; Inborn urea cycle disorders
- Focus Therapeutic Use
- Acronyms THRIVE
- 08 Nov 2013 New trial record